HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neurofibromatosis-related tumors: emerging biology and therapies.

AbstractPURPOSE OF REVIEW:
Over the past decade, substantial insight into the biological function of the tumor suppressors neurofibromin (NF1) and Merlin (NF2) has been gained. The purpose of this review is to highlight some of the major advances in our understanding of the biology of neurofibromatosis type 1 (NF1) and neurofibromatosis type 2 (NF2) as they relate to the development of novel therapies for these disorders.
RECENT FINDINGS:
The development of increasingly sophisticated preclinical models over the recent years has provided the platform from which to rationally develop molecular targeted therapies for both NF1 and NF2-related tumors, such as within the Department of Defense-sponsored Neurofibromatosis Clinical Trials Consortium.
SUMMARY:
Clinical trials with molecular-targeted therapies have become a reality for neurofibromatosis patients, and hold substantial promise for improving the morbidity and mortality of individuals affected with these disorders.
AuthorsMatthias A Karajannis, Rosalie E Ferner
JournalCurrent opinion in pediatrics (Curr Opin Pediatr) Vol. 27 Issue 1 Pg. 26-33 (Feb 2015) ISSN: 1531-698X [Electronic] United States
PMID25490687 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Antineoplastic Agents
  • Neurofibromin 1
  • Neurofibromin 2
Topics
  • Antineoplastic Agents (therapeutic use)
  • Child
  • Child, Preschool
  • Clinical Trials as Topic
  • Gene Expression Regulation, Neoplastic
  • Genetic Predisposition to Disease
  • Humans
  • Infant
  • Magnetic Resonance Imaging
  • Molecular Targeted Therapy (trends)
  • Nerve Sheath Neoplasms (genetics, pathology, therapy)
  • Neurofibromatosis 1 (genetics, pathology, therapy)
  • Neurofibromatosis 2 (genetics, pathology, therapy)
  • Neurofibromin 1 (genetics, metabolism)
  • Neurofibromin 2 (genetics)
  • Peripheral Nervous System Neoplasms (genetics, pathology, therapy)
  • Skin Neoplasms (genetics, pathology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: